Last $113.00 USD
Change Today 0.00 / 0.00%
Volume 0.0
AKBLF On Other Exchanges
Symbol
Exchange
Copenhagen
OTC US
Berlin
OTC US
As of 8:10 PM 12/11/14 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

Bøge Allé 6-8

Hørsholm, 2970

Denmark

Phone: 45 45 74 75 76

Fax: 45 45 74 86 07

ALK-Abelló A/S, a pharmaceutical company, engages in the research and development, production, and sale of products for the diagnosis, prevention, and treatment of allergies. The company offers allergy immunotherapy products as injections, sublingual drops, and tablets. It provides GRAZAX, a tablet-based vaccine for grass pollen allergy; SLITone, a droplet-based allergy vaccine for daily administration through a single-dose container; and Alutard SQ, a product for subcutaneous allergy vaccination. The company’s products also include JEXT, an adrenaline auto-injector used to treat acute allergic reactions; and AVANZ, an injection based immunotherapy product. Its products in pipeline comprise Grass AIT, which has completed Phase III clinical trial for the treatment of grass allergic rhinoconjunctivitis (ARC); GRAZAX that is in Phase III clinical trial for asthma prevention; Ragweed AIT, a Phase III clinical trial product for ragweed ARC; HDM AIT for the treatment of house dust mite asthma and rhinitis; and Tree AIT, a Phase II clinical trial product for the treatment of tree ARC. In addition, the company focuses on developing AIT products against Japanese cedar pollen allergy; and products for cat allergies, as well as manufactures allergen extracts for allergy testing, such as skin-prick tests. The company provides its products through distributors worldwide. ALK-Abelló A/S has partnership agreements with Merck & Co., Inc. and Torii Pharmaceutical Co., Ltd. to develop, register, and commercialize tablets in North America and Japan. The company was founded in 1923 and is headquartered in Hørsholm, Denmark.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AKBLF:US $113.00 USD 0.00

AKBLF Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Allergy Therapeutics PLC 23.88 GBp +0.25
DBV Technologies SA €43.80 EUR +1.36
Merck & Co Inc $59.58 USD +0.60
Sanofi €75.38 EUR -0.79
Stallergenes SA €48.25 EUR -0.38
View Industry Companies
 

Industry Analysis

AKBLF

Industry Average

Valuation AKBLF Industry Range
Price/Earnings 30.9x
Price/Sales 2.6x
Price/Book 2.6x
Price/Cash Flow 28.8x
TEV/Sales 2.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALK-ABELLO A/S, please visit www.alk-abello.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.